OHR Pharmaceutical Inc (NASDAQ:OHRP)

0.257
Delayed Data
As of Feb 21
 -0.003 / -1.15%
Today’s Change
0.24
Today|||52-Week Range
2.18
-86.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization466.3K1.2M1.2M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income-466.3K-1.2M-1.2M-1.2M
 
 
 
 
 
General Expenses8.7M16.3M24.1M22.7M
 
 
 
 
 
Other Operating Expenses0.000.000.00-70.8K
 
 
Research And Development3.5M8.8M16.5M17.4M
 
 
 
 
 
Total Operating Expenses9.1M17.5M25.3M23.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.1M-17.5M-25.3M-23.8M
 
 
 
 
 
Extraordinary Credit0.002.6M710.3K0.00
 
 
 
Extraordinary Charge0.00-338.9K-1.2M0.00
 
 
 
Pre-Tax Equity Earnings-10.6K-103.1K0.000.00
 
 
 
Interest Expense On Debt5.6K6.0K0.0029.6K
 
 
 
 
Other Expenses8.5K78.8K3.4K-1.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.1M-15.2M-25.8M-23.8M
 
 
 
 
 
Net Income-9.1M-15.2M-25.8M-23.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.1M28.4M31.3M44.8M
 
 
 
 
 
Shares To Calculate EPS Diluted22.1M28.4M31.3M44.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.41-$0.54-$0.82-$0.53
 
 
 
 
 
EPS Diluted-$0.41-$0.54-$0.82-$0.53